Rewriting Life Amgen Finds Anti-Heart Attack Gene Massive gene studies are letting biotechnology companies learn from nature, and imitate it. by Antonio Regalado 2016-05-18T18:18:00-04:00
Rewriting Life The Drug-Making Process Is Slow and Wasteful—This Machine Could Fix That A portable assembly line for medicines offers a better way to respond to outbreaks and shortages. by Mike Orcutt 2016-04-12T00:00:00-04:00
Rewriting Life Female Viagra Is Found Lacking as “Predatory” Drugmaker Valeant Falls Further The drug company has earned the ire of Hillary Clinton, is under several investigations, and was met with a collective “meh” from women who tried its “female Viagra” pill. by Antonio Regalado 2016-03-01T16:32:00-05:00
Rewriting Life Unraveling the Mysterious Function of the Microbiome A new class of experimental therapies is emerging from the study of how the community of microörganisms in your body contributes to disease. by Mike Orcutt 2016-02-09T00:00:00-05:00
Rewriting Life Companies Aim to Make Drugs from Bacteria That Live in the Gut Relatively new discoveries about of the role of the microbiome in human health have sparked a race to develop new therapies based on microbes. by Mike Orcutt 2016-01-18T00:00:00-05:00
Rewriting Life Big Pharma Doubles Down on CRISPR for New Drugs A joint venture between Bayer and CRISPR Therapeutics is the latest effort to make CRISPR drugs that could target and modify cells inside the body. by Mike Orcutt 2016-01-13T00:00:00-05:00
Rewriting Life DNA-Based Research May Have Unveiled Long-Sought Diabetes Treatment A synthetic drug that controls blood sugar in obese mice demonstrates the potential of a DNA-dependent method for developing new chemical compounds. by Susan Young Rojahn 2014-05-23T13:00:00-04:00
Rewriting Life The Revival of Cancer Immunotherapy An old idea for treating cancer is yielding impressive results on cancer patients—and lots of attention from drug companies. by Susan Young Rojahn 2014-04-07T00:00:00-04:00
Rewriting Life Startup Finds Hope in Second Look at “Failed” Alzheimer’s Drugs A startup will sift through “treasure troves” of data from failed trials to find abandoned Alzheimer’s drugs that might work for some patients. by Susan Young Rojahn 2013-10-30T00:00:00-04:00
Rewriting Life Cancer Drugs Should Cost Less, Say Doctors Doctors argue that some drug companies are charging too much for their cancer drugs, to the detriment of patients. by Susan Young Rojahn 2013-04-29T12:41:44-04:00
